TickerGuard
Buy Day today: Neutral (59) Mixed market breadth · major macro event coming up
ONC

BeiGene, Ltd.

Healthcare · Biotechnology

356.00$ -0.8% vs. previous close Closing price · As of: Aug 13, 2026

Statements

Cash Flow

BeiGene, Ltd. (ONC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 664 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ONC
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
-24 -26 -36 -52 6.6 94 -105 -117 -132 -194 -172 -46 -265 -267 -342 -263 -346 -332 125 -420 -496 -508 -237 -380 -562 -318 -564 -294 -78 -222 -309 -96 188 75 44 264 403 417 202 664 1,686
0.5 0.5 0.9 0.5 1.3 2.1 2.2 2.3 2.4 3.4 3.4 3.7 4.0 7.5 7.8 7.9 8.3 7.8 9.6 12 12 13 17 15 16 18 20 22 22 24 25 25 71 50 33 36 37 210 41 82 370
2.8 3.9 6.0 7.1 13 16 17 19 25 26 26 33 37 38 38 45 50 49 46 65 67 63 66 81 78 78 75 103 96 93 89 131 115 108 95 151 141 757 123 261 1,282
7.8 6.7 10 0.8 -126 172 -26 24 -14 -0.6 -60 -16 16 49 -35 63 15 107 25 -43 -89 -11 122 96 -86 -0.2 -294 -35 -58 17 -155 -113 130 -19 -78 5.4 100 164 -190 -119 -45
6.7 8.1 7.4 14 19 19 20 11 27 84 51 41 31 35 65 33 75 57 51 39 67 158 120 50 129 170 126 121 182 167 193 110 134 92 116 64 48 286 41 68 443
44 -171 44 70 -401 -68 -394 34 -491 213 172 192 214 -24 -1,115 -430 -1,537 -87 292 252 -12 109 210 659 169 39 241 68 -186 -63 -210 -111 -134 -94 -122 -67 -49 -39 -46 -95 -228
-3.6 -13 -97 26 -4.3 79 51 -17 108
7.6 199 2.5 145 340 3.0 764 47 871 8.8 43 15 25 2.2 2,802 81 1,994 326 107 36 109 3,385 -11 -18 120 -110 -20 166 -77 347 162 23 13 -4.5 -34 35 961 98 69 63 1,191
27 2.0 10 163 -52 31 268 -38 241 30 48 154 -42 -280 1,339 -610 120 -80 520 -124 -397 2,993 -28 181 -335 -325 -331 -122 -341 105 -379 -190 95 -75 -108 255 1,324 499 244 671 2,738
-31 -34 -43 -66 -12 75 -124 -128 -159 -277 -223 -88 -296 -303 -406 -296 -421 -389 74 -459 -563 -666 -357 -430 -691 -488 -689 -415 -260 -389 -502 -206 55 -17 -72 200 354 131 161 596 1,243

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?